Published March 2002 | Version v1
Journal article

In vivo tumor localization and biodistribution in the human tumor xenografts models of an anti-CD71 mouse/human chimeric antibody

  • 1. Jianghan Univ., Wuhan (China). College of Medicine and Life Science
  • 2. Tongji Medical College of Huazhong Univ. of Science and Technology, Wuhan (China). Inst. of Immunology
  • 3. Union Hospital of Tongji Medical College of Huazhong Univ. of Science and Technology, Wuhan (China). Dept. of Nuclear Medicine

Description

Objective: In order to investigate the tumor localization and biodistribution of the anti-CD71 mouse/human chimeric antibody (D2C). Methods: The tumor localization and biodistribution of the chimeric antibody (D2C) were observed by labeling the chimeric Ab with radioiodine (131I) and injecting it into nude mice (Balb/c nu/nu) transplanted with human hepatocellular carcinoma cells (SMMC-7721). Results: The labeled chimeric Ab (D2C), with intraperitoneal as well as tumor regional administration, was significantly localized in the tumor and the location of the tumor was successfully visualized by SPECT. The in vivo D2C Ab's biodistribution of organs and tissues showed that non-specific binding in the tumor regional administration was lower than those in the intraperitoneal. Conclusion: The human/mouse chimeric antibody (D2C) can exert in specific tumor localization in vivo and can be utilized for radio-immunoimaging

Additional details

Publishing Information

Journal Title
Asian Journal of Nuclear Medicine
Journal Volume
2
Journal Issue
1
Journal Page Range
p. 29-32
ISSN
1607-680X